Depression Risk
Study register · detail Longitudinale Kohortenstudie · Depression Risk · 2014

Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.

Mixed GRADE Low 37 citations
Samplen = 705 Pat.
Duration6 months to 5 years
EndpointCAPE
Blindingn.a.
DesignLongitudinale Kohortenstudie
Key finding

Decrease in cannabis use is accompanied by fewer psychotic experiences, increase by more positive symptoms, but not by negative or depressive symptoms.

Summary

Longitudinal study (N=705, age 18–27 years, follow-up 6 months to 5 years): Increase in cannabis use was NOT significantly associated with an increase in depressive symptom scores (β not significant). Decrease in use was significantly associated with a decrease in overall psychotic experiences (β=−0,096; p=0,01). No evidence for cannabis as a risk factor for depressive symptoms in this age group.

P
PopulationYoung adults (18–27 years) from the general population, n=705
I
InterventionChange in cannabis use (increase or decrease) over the observation period
O
OutcomeDecrease in cannabis use associated with decrease in psychotic experiences (β=-0.096, p=0.01); increase in use associated with increased positive symptoms (β=0.07, p=0.02), not significant for negative and depressive symptoms
Confidence in the evidence
Low

The second of four GRADE levels, the effect estimate is of limited reliability.

Quality profile
Sample size
Blinding
Effect size Mixed
Citations / year
Authors
van Gastel WA, Vreeker A, Schubart CD, MacCabe JH, Kahn RS, Boks MP.
DOI 10.1016/j.schres.2014.04.023
Design: Longitudinale Kohortenstudie
Share
Abstract
<h4>Objective</h4>To prospectively assess the relationship between cannabis use and psychotic experiences over time.<h4>Method</h4>In a longitudinal design, young adults aged 18-27years (N=705) gave online information on cannabis use and completed the Community Assessment of Psychic Experiences (CAPE). These measures were repeated after an interval ranging from six months to five years.<h4>Results</h4>A decrease in cannabis use was associated with a decrease in total psychotic experiences (β=-0.096, p=0.01) after adjustment for a range of potential confounders. An increase in cannabis use was associated with increased positive symptoms at follow-up (β=0.07, p=0.02), but was not significantly associated with increases in Negative and Depression symptom scores, nor with the total number of psychotic experiences.<h4>Conclusion</h4>In the first study to the association of change in cannabis use and psychotic experiences over time in the general population, we found an association between changes in cannabis use and changes in the frequency of psychotic experiences. While this does not prove a causal relationship between cannabis use and psychosis, our findings are consistent with studies suggesting that cessation of cannabis use may be beneficial in terms of reducing psychotic experiences.

The impediment to action advances action. — Marcus Aurelius